Medical News

RSS

Researchers identify molecular cause of age-related cognitive decline

A research team from University Hospitals, Case Western Reserve University and the Louis Stokes Cleveland VA Medical Center has identified a critical molecular cause of age-related cognitive decline, potentially paving the way for new treatments to protect brain health as we age.

23 Jun 2026

New polymer hydrogel contact lenses heal scratches with UV light

Contact lenses are a great vision correction option for many, but if one of them gets damaged, there is little to do other than throw it away.

23 Jun 2026

Electroacupuncture at Lianquan point restores post-stroke swallowing function

Swallowing is a complex act requiring precise coordination of the mouth, throat, and voice box. After a stroke, damage to the brain's motor cortex can disrupt swallowing-related neural commands, leaving patients unable to clear food or liquid from their throat safely.

23 Jun 2026

Aligned heart rates indicate real-world social connection and engagement

When people are close-both physically and emotionally-their heart rates begin to align, rising and falling together. Could such cardiac alignment be used as a way to measure social engagement and connection in everyday settings? Hanlu He and colleagues used data collected by 72 students visiting New York City as part of an audio engineering competition.

23 Jun 2026

Skin barrier monitoring predicts necrosis after skin flap surgery

Random-pattern skin flaps (RPSFs) receive blood mainly from small subcutaneous vessels rather than a defined axial vessel, leaving them vulnerable to ischemia and hypoxia after surgery.

23 Jun 2026

New miniature dental robot could automatically prepare teeth for crowns

Researchers at the University of Basel have developed a miniature dental robot that could one day automatically prepare teeth for crowns.

23 Jun 2026

COPD patients lack critical health information during major wildfire events

Wildfire smoke can trigger breathing problems and flare-ups for people with chronic obstructive pulmonary disease (COPD), yet many people are not receiving the trusted health information they need to stay safe, according to a new study in the May 2026 issue of Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, a peer-reviewed, open access journal.

23 Jun 2026

Researchers trace soaring poison control calls to semaglutide approval for weight loss

When semaglutide's popularity exploded following FDA approval for weight management in 2021, so too did a wave of calls to poison control centers.

23 Jun 2026

Scientists discover how food poisoning bacteria protect themselves from antibiotics

Scientists from the Department of Microbiology of the University of Malaga, also members of the Institute of Subtropical and Mediterranean Horticulture 'La Mayora' (IHSM), have discovered a hitherto unknown mechanism that allows the bacterium Bacillus cereus, which is responsible for food poisoning and human infections, to protect itself against antibiotics and adverse conditions.

23 Jun 2026

UCI Health launches world's first embryonic stem cell trial for Huntington's disease

UCI Health, the clinical enterprise of the University of California, Irvine, has opened the world's first in-human embryonic stem cell-derived clinical trial for Huntington's disease.

23 Jun 2026

NIH funding supports development of AI tools to prevent HIV, hepatitis C and overdose

Natasha Martin, DPhil, professor and vice chief of Global Public Health in the Division of Infectious Diseases and Global Public Health at UC San Diego School of Medicine, has been awarded a five-year, $5.6 million Avant-Garde Award from the National Institute on Drug Abuse (NIDA), one of the most prestigious and competitive NIH research awards.

23 Jun 2026

Artificial intelligence helps breast cancer patients avoid unnecessary chemotherapy

Research led by RCSI University of Medicine and Health Sciences and University College Dublin (UCD) has identified immune markers that could help doctors more accurately determine which breast cancer patients are unlikely to benefit from chemotherapy, potentially sparing some patients from unnecessary treatment.

23 Jun 2026

Researchers identify control switch protein that starves tuberculosis bacteria

A protein that acts as a 'control switch,' preventing Mycobacterium tuberculosis from accessing the energy sources it needs to survive, has been identified by researchers at the University of Surrey.

23 Jun 2026

Synthetic protein hybrid offers promising treatment for liver diseases

The research group led by CIC biomaGUNE's Ikerbasque Research Professor Aitziber L. Cortajarena has developed an innovative anti-fibrotic and anti-tumor treatment by binding a synthetic protein to gold nanoclusters (small aggregates of approximately 6 atoms of gold).

23 Jun 2026

New project aims to systematically map billion cellular interactions

...

23 Jun 2026

Curtin University projects explore youth health issues in Western Australia

Curtin University Curtin University researchers will examine the 'partygoing' behaviours of young people in regional areas, the use of nicotine pouches and ways to promote physical activity among young people as part of new projects funded by Healthway.

23 Jun 2026

New TRUECAM wrapper makes medical artificial intelligence more trustworthy

Medical artificial intelligence (AI) faces a fundamental challenge: uncertainty quantification. Artificial neural networks are largely unaware of the limits of their training data and can become overconfident when confronted with unfamiliar inputs. Suppose you train a neural network to distinguish among African mammals.

23 Jun 2026

Stockholm3 blood test may offer more accurate prostate cancer detection

...

23 Jun 2026

Revolutionary protective shoe concept provides increased comfort and minimizes strain

A revolutionary protective shoe concept adapts to the needs of users in a new way and provides increased comfort and minimizes strain.

23 Jun 2026

TRIMTECH Therapeutics brings total seed round to $47 M with additional investment of $14 M to further develop TRIMTAC and TRIMGLUE targeted protein degradation portfolio

TRIMTECH Therapeutics, a biotechnology company developing novel small molecule therapies that target and degrade protein aggregates associated with neurodegenerative diseases, today announced it has raised an additional $14 million in seed funding, bringing the total for the round to $47 million (£35 million).

From TRIMTECH Therapeutics 23 Jun 2026